Earnings Call · Q2 FY2026·2025-12-15

Q2 26EPS +100.00%*·Rev n/aQ1 26EPS +100.00%*·Rev n/aQ4 25EPS -100.00%*·Rev n/aQ3 25EPS +100.00%*·Rev n/a⚠ consensus missing

CHAMPIONS ONCOLOGY, INC. CSBR

Robert Brainin — Chief Executive Officer

David Miller — Chief Financial Officer

−13.7%1d on move date−13.4% vs SPY3d−7.4%5d−7.1%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CSBR calls or request research access.

More CSBR calls Browse calls Request research access